Bali Muralidhar - Global Head of Life Sciences @ Abingworth

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

CB Rank (Investor)

75,754

Primary Job Title Global Head of Life Sciences
Primary Organization
Abingworth

Location London, England, United Kingdom
Regions Europe, Middle East, and Africa (EMEA)
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Bali Muralidhar is based out of London and is the Global Head of Life Sciences of Abingworth. Bali previously worked at MVM Partners as a Partner. Bali Muralidhar attended the University of Cambridge. Bali Muralidhar has been received Financial News’ Rising Stars in Private Equity Award in their career.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Cytospire Therapeutics	Abingworth	—	Series A - Cytospire Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Wugen	Abingworth	—	Series C - Wugen	obfuscated obfuscation
obfuscated obfuscation	Glycomine	Abingworth	—	Series C - Glycomine	obfuscated obfuscation
obfuscated obfuscation	AdvanCell	Abingworth	Yes	Series C - AdvanCell	obfuscated obfuscation
obfuscated obfuscation	Ascend Gene & Cell Therapies	Abingworth	Yes	Series A - Ascend Gene & Cell Therapies	obfuscated obfuscation
obfuscated obfuscation	Anjarium Biosciences	Abingworth	Yes	Series A - Anjarium Biosciences	obfuscated obfuscation
obfuscated obfuscation	CymaBay Therapeutics	Abingworth	Yes	Post-IPO Debt - CymaBay Therapeutics	obfuscated obfuscation
obfuscated obfuscation	Wugen	Abingworth	Yes	Series B - Wugen	obfuscated obfuscation
obfuscated obfuscation	Glycomine	Abingworth	Yes	Series B - Glycomine	obfuscated obfuscation
obfuscated obfuscation	Reneo Pharmaceuticals	Abingworth	Yes	Series B - Reneo Pharmaceuticals	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Bali Muralidhar

has

current jobs including

Global Head of Life Sciences

Abingworth

Non-Executive Director

British Business Bank

, and

Managing Partner, Chief Investment Officer

Abingworth

. Additionally,

Bali Muralidhar

has had

past jobs including

Partner

Abingworth

Abingworth Global Head of Life SciencesJan 2026
British Business Bank Non-Executive DirectorJun 2025
Abingworth Managing Partner, Chief Investment OfficerAug 2022
Abingworth Managing PartnerDec 2020

Organization Name	Title At Company	Start Date	End Date
Abingworth	Partner	Apr 2019	Dec 2020
MVM Life Science Partners	Partner	Nov 2012	Apr 2019
Bain Capital	Associate	Apr 2011	Nov 2012
Bain & Company	Consultant	2008	2011

Board and Advisor Roles

Number of Current Board & Advisor Roles

Bali Muralidhar

holds

board and advisor roles including

Board of Directors

Anjarium Biosciences

Board of Directors

Glycomine

, and

Board Member

Cytospire Therapeutics

Anjarium Biosciences Board of DirectorsSep 15, 2021
Glycomine Board of DirectorsJun 23, 2021
Cytospire Therapeutics Board Member
Wugen Board Member
Wilson Therapeutics Board of Directors
AdvanCell Board Member

Related Hubs

Hub Name	CB Rank (Hub)
London Acquired Companies With More Than 10 Employees	3,250
Private Equity Firms with Investments in England	16,172
United Kingdom Acquired Companies With More Than 10 Employees	529
Venture Stage Investors Private Equity Firms	11,464
Investors Active in England	1,282
London Biotechnology Companies	7,929
Health Diagnostics Companies With More Than 10 Employees (Top 10K)	5,586
Europe, Middle East, and Africa (EMEA) Investors with Funds Raised in 2014	39,239
Europe, Middle East, and Africa (EMEA) Venture Capital Investors	2,052
United Kingdom Venture Capital Investors	10,434